Analgesics Market to Reach $50.7 Bn, Globally, by 2030 at 6.6% CAGR: Allied Market Research
Surge in incidences of chronic diseases such as tuberculosis (TB), cancer, cardiovascular diseases, and arthritis drives the growth of the global analgesics market.
PORTLAND, Ore., May 19, 2022 /PRNewswire/ -- Allied Market Research published a report, titled, "Analgesics Market by Type (Non opioids, Opioids), by Route of Administration (Oral, Intravenous, Rectal, Transdermal, and Topical): Global Opportunity Analysis and Industry Forecast, 2020-2030." According to the report, the global analgesics industry was estimated at $26.7 billion in 2020, and is anticipated to hit $50.7 billion by 2030, registering a CAGR of 6.6% from 2021 to 2030.
Download Sample PDF at: https://www.alliedmarketresearch.com/request-sample/1254
Drivers, restraints, and opportunities-
Surge in incidences of chronic diseases such as tuberculosis (TB), cancer, cardiovascular diseases, and arthritis drives the growth of the global analgesics market. At the same time, rise in number of clinical studies for evaluating the safety and efficiency of a wide range of therapeutic drugs has supplemented the market growth yet more. However, technological development in the pharmaceutical industry to manufacture advanced analgesic drugs is expected to provide lucrative opportunities in the industry.
Covid-19 scenario-
- The outbreak of the pandemic gave way to increasing demand for analgesic drugs such as paracetamol, thereby impacting the global analgesics market positively.
- This trend is pretty likely to continue till the pandemic is completely over.
Specific Requirement on COVID-19? Ask to Our Industry Expert: https://www.alliedmarketresearch.com/purchase-enquiry/1254
The non-opioids drugs segment to dominate by 2030-
By type, the non-opioids drugs segment contributed to the major share in 2020, holding more than three-fourths of the global analgesics market. This is attributed to the high use of non-opioid analgesics for pain relief along with lower adverse effects and the initiatives taken by government and private organizations about the use of non-opioids drugs as a painkiller. The opioids segment, however, would cite the fastest CAGR of 7.2% during the forecast period. Increase in incidences of chronic diseases such as tuberculosis (TB), cardiovascular diseases, arthritis, and cancer, and surge in number of surgical procedures fuel the segment growth.
The oral segment to maintain the lion's share-
By route of administration, the oral segment accounted for the major share in 2020, holding more than half of the global analgesics market. This is because simple administration of analgesics by the oral route is non-invasive in nature, and is highly effective as compared to other routes of administration. The intravenous segment, on the other hand, is expected to grow at the fastest CAGR of 7.5% from 2021 to 2030. Advancement in technology in the healthcare sector and emergence of analgesic drugs drive the segment growth.
North America garnered the major share in 2020-
By region, the market across North America had the lion's share in 2020, generating nearly one-third of the global analgesics market, owing to increase in demand for non-opioids drugs, presence of key players, and development in R&D activities in the healthcare sector in the province. The Asia-Pacific region, on the other hand, is projected to portray the fastest CAGR of 7.3% by 2030. This is due to rise in awareness about the use of analgesic drugs, growth in healthcare expenditures, and surge in adoption of analgesic products.
Key players in the industry-
- Novartis AG
- Eli Lily and Company
- Glaxosmithkline PLC
- Pfizer Inc.
- Sanofi
- Bayer AG
- Johnson & Johnson
- Bristol Myer's Squibb
- Reckitt Benckiser
- Endo Pharmaceuticals
Avenue Basic Plan | Library Access | 1 Year Subscription |
Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.
Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter
"We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market."
Trending Reports in Healthcare Industry (Book Now with 10% Discount):
Neuromodulation Market - Global Opportunity Analysis and Industry Forecast, 2020–2028
Cataract Surgery Devices Market - Global Opportunity Analysis and Industry Forecast, 2020-2028
Ulcerative Colitis Market - Global Opportunity Analysis and Industry Forecast, 2020-2028
Contrast Injector Systems Market - Global Opportunity Analysis and Industry Forecast, 2020–2028
Ureteral Stents Market - Global Opportunity Analysis and Industry Forecast, 2020–2028
Membrane Microfiltration Market - Global Opportunity Analysis and Industry Forecast, 2020–2028
Renal Denervation Market - Global Opportunity Analysis and Industry Forecast, 2020–2028
Contraceptives Market - Global Opportunity Analysis and Industry Forecast, 2020–2028
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): 1-800-792-5285, 1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com/reports-store/life-sciences
Follow Us on LinkedIn: https://www.linkedin.com/showcase/life-sciences-industry-research/
Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg
Share this article